Skip to content
healthcare.dev
Get a free key

VITRAKVI

NDC 71777-391, LAROTRECTINIB, capsule, from Loxo Oncology, Inc..

Product NDC
71777-391
Status
Listed
Labeler
Loxo Oncology, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA210861
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71777-391 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAROTRECTINIB100 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Tropomyosin Receptor Kinases Inhibitors [MoA]

Package NDCNDC-11Package
71777-391-017177703910160 CAPSULE in 1 BOTTLE (71777-391-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9525f887-a055-4e33-8e92-898d42828cd1

Use it

Look up 71777-391 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71777-391 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71777-391. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.